Day 1, Session V, VI and Lifetime Accelerator Award

 

SESSION V: Late-Stage and Approved Devices--What is New? moderated by, Daniel Friedman, MD, Assistant Professor of Neurology, New York University

This 6 presentations session includes:

  • Medtronic, Inc. | DBS Therapy for Epilepsy
    Jon Giftakis, PhD, Senior Principal Scientist, Medtronic Neuromodulation
    Starts at 0:47
     
  • NeuroSigma, Inc. | eTNS
    Christopher DeGiorgio, MD, Professor of Neurology, UCLA
    Starts at 10:40
     
  • UCLA | Ultrasound for Seizure Modulation
    John Stern, MD, Director, Epilepsy Clinical Program, UCLA Department of Neurology, Co-Director, UCLA Seizure Disorder Center
    Starts at 23:15
     
  • Visualase, Inc. | Laser Ablation in Neurosurgery
    Ashok Gowda, PhD, Founder and Chief Operating Officer
    Starts at 32:18
     
  • Swedish Neuroscience Institute | MR-guided Focused Ultrasound for Treatment of Mesial TLE
    John Snell, PhD, Technical Director-Brain Program, Focused Ultrasound Foundation
    Starts at 46:10
     
  • Boston Children's Hospital | TMS
    Alexander Rotenberg, PhD, MD, Director, Neuromodulation Program, Associate Professor of Neurology, Boston Children's Hospital, Harvard Medical School
    No powerpoint available during broadcast. Speaker made the above PDF available for offline viewing.

    Starts at 57:09

SESSION VI: Nonprofit Organization, Government and Crowdfunding--Grants, Awards and Funding to Advance Research to the Next Critical Stage, moderated by Roger J. Porter, MD, Chief Scientific Officer, Epilepsy Foundation.
Starts at 1:11:12

This 6 presentations session and panel includes:

  • Jan Buelow, PhD, Vice President Programs and Research, Epilepsy Foundation
     
  • Rajesh Ranganathan, PhD, Director, Office of Translational Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health | Blueprint Program
     
  • H. Steve White, PhD, Research Director, Citizen's United for Research in Epilepsy (CURE), Professor and Director, Anticonvulsant Drug Development Program, University of Utah
     
  • Bre DiGiammarino, Cause Director, Indiegogo | Crowdfunding -- n. & v. The pooling of small contributions of funds from a group of people for the purpose of making something larger happen

Lifetime Accelerator Award: Honoring H. Steve White, PhD
Starts at 2:01:30

<< Previous Video:
Day 1, Early-Stage Diagnostic Devices and Product Pipeline: New Concepts and Initial Findings

>> Next Video:
Day 2, New Directions and Opportunities in Epilepsy Research

ADVERTISEMENT
2014 Epilepsy Pipeline Conference

On June 5-7, 2014 in San Francisco, CA, the Epilepsy Therapy Project, an initiative of the Epilepsy Foundation presented the 4th Biennial Epilepsy Pipeline Conference 2014, held at the Hyatt Regency, San Francisco.

Showcasing the most promising epilepsy therapies from healthcare companies dedicated to pioneering and advancing drugs, biologics, technologies and devices for epilepsy and seizures, this year's conference featured the third annual "Shark Tank" competition, in addition to a day designated for people with epilepsy, families and advocates. The conference brought together decision-makers with a stake in the field of epilepsy treatment, therapeutic innovation and product development. Speakers and attendees included emerging biotech and medical technology companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances.

Read the press release for more information

ADVERTISEMENT